Zoladex 3.6mg Injection

About Zoladex 3.6mg Injection

Zoladex 3.6mg Injection contains Goserelin Acetate, a hormone therapy medication that belongs to the luteinizing hormone-releasing hormone (LHRH) agonist class. It is widely used in the treatment of hormone-sensitive cancers and gynecological conditions. In men, Zoladex 3.6mg Injection is prescribed alone or in combination with other therapies for the treatment of localized and advanced prostate cancer by reducing testosterone levels, which helps slow the growth of cancer cells. In women, it is used to manage advanced breast cancer, endometriosis, uterine fibroids, infertility treatment protocols, and to thin the uterine lining before certain surgical procedures. Zoladex works by lowering estrogen levels in women and testosterone levels in men, thereby reducing hormone-dependent disease activity. Patients should inform their healthcare provider immediately if they experience pain, swelling, bleeding, or injury at the injection site after administration. This medication is not recommended during pregnancy or breastfeeding and should not be used in children. Before starting treatment, patients should disclose any history of high blood pressure, heart disease, irregular heart rhythms, or mental health conditions such as depression and anxiety, as close monitoring may be required. Common side effects in men include hot flashes, urinary tract infections, reduced libido, and sexual dysfunction, while women may experience hot flashes, acne, increased sweating, mood changes, and depression. Regular medical follow-up is essential to monitor treatment response and manage potential side effects effectively.